Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
5.25
-0.04 (-0.66%)
At close: Jul 10, 2025, 4:00 PM
5.24
0.00 (-0.10%)
After-hours: Jul 10, 2025, 7:06 PM EDT
Rezolute Market Cap
Rezolute has a market cap or net worth of $448.55 million as of July 10, 2025. Its market cap has increased by 183.00% in one year.
Market Cap
448.55M
Enterprise Value
362.35M
1-Year Change
183.00%
Ranking
Category
Stock Price
$5.25
Market Cap Chart
Since November 10, 2020, Rezolute's market cap has increased from $167.00M to $448.55M, an increase of 168.59%. That is a compound annual growth rate of 23.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2025 | 451.50M | 59.03% |
| Dec 31, 2024 | 283.90M | 622.39% |
| Dec 29, 2023 | 39.30M | -48.43% |
| Dec 30, 2022 | 76.20M | 3.25% |
| Dec 31, 2021 | 73.80M | -26.27% |
| Dec 31, 2020 | 100.10M | -40.06% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 709.79B |
| Johnson & Johnson | 379.41B |
| AbbVie | 344.45B |
| Novo Nordisk | 316.64B |
| UnitedHealth Group | 271.70B |
| Novartis AG | 243.81B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 223.49B |